Skip Navigation
Faculty Publications

representative sampling

Ahmed MM, Sheldon D, Fruitwala MA, Venkatasubbarao K, Lee EY, Gupta S, Wood C, Mohiuddin M, Strodel WE. “Downregulation of PAR-4, a pro-apoptotic gene, in pancreatic tumors harboring K-ras mutation.” Int J Cancer. 2008 Jan 1;122(1):63-70. (http://www.ncbi.nlm.nih.gov/pubmed/17893871)

Brady J, Riccio JA, Yumen OH, Makary AZ, Greenwood SM. “Plasmapheresis. A therapeutic option in the management of heparin-associated thrombocytopenia with thrombosis.” Am J Clin Pathol. 1991 Sep;96(3):394-7. (http://www.ncbi.nlm.nih.gov/pubmed/1877539)

Boctor FN, Gorak E, Prichard JW, Firouzi M, Difilippo W. “Unusual warm autoimmune hemolytic anemia in non-alcoholic steatohepatitis.” Ann Clin Lab Sci. 2008 Summer;38(3):273-6. (http://www.ncbi.nlm.nih.gov/pubmed/18715857)

Fata F, Mirza A, Bernath A. “Skin lesions in melanoma and Kaposi's sarcoma. Case 3. Familial classic Mediterranean Kaposi's sarcoma.” J Clin Oncol. 2002 Mar 1;20(5):1415-8. (http://www.ncbi.nlm.nih.gov/pubmed/11870189)

Fata F, Mirza A, Craig G, Nair S, Law A, Gallagher J, Ellison N, Bernath A. “Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center.” Cancer. 2002 Apr 1; 94(7):1931-8. (http://www.ncbi.nlm.nih.gov/pubmed/11932894)

Haider FS, Smith R, Khan S. “Primary hepatic lymphoma presenting as fulminant hepatic failure with hyperferritinemia: a case report.” J Med Case Reports. 2008 Aug 19;2:279. (http://www.ncbi.nlm.nih.gov/pubmed/18710584)

Law A, Kennedy T, Pellitteri P, Wood C, Christie D, Yumen O. “Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck.” Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1361-8. Epub 2007 Sep 14. (http://www.ncbi.nlm.nih.gov/pubmed/17869022)

Lin F, Zhang K, Quiery AT Jr, Prichard J, Schuerch C. Plasmablastic lymphoma of the cervical lymph nodes in a human immunodeficiency virus-negative patient: a case report and review of the literature.” Arch Pathol Lab Med. 2004 May;128(5):581-4. (http://www.ncbi.nlm.nih.gov/pubmed/15086296)

Mohiuddin M, Marks J, Marks G. “Management of rectal cancer: short- vs. long-course preoperative radiation.” Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):636-43. (http://www.ncbi.nlm.nih.gov/pubmed/19014778)

Mohiuddin M, Mohiuddin MM, Marks J, Marks G. “Future directions in neoadjuvant therapy of rectal cancer: maximizing pathological complete response rates.” Cancer Treat Rev. 2009 Nov;35(7):547-52. Epub 2009 Jun 17. (http://www.ncbi.nlm.nih.gov/pubmed/19539429)

Reeves A, Zagurovskaya M, Gupta S, Shareef MM, Mohiuddin M, Ahmed MM. “Inhibition of transforming growth factor-beta signaling in normal lung epithelial cells confers resistance to ionizing radiation.” Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):187-95. (http://www.ncbi.nlm.nih.gov/pubmed/17448872)

Sabri M, Di Lorenzo C, Henderson W, Thompson W, Barksdale E Jr, Khan S. “Colon cleansing with oral sodium phosphate in adolescents: dose, efficacy, acceptability, and safety.” Am J Gastroenterol. 2008 Jun;103(6):1533-9; quiz 1540. Epub 2008 May 28. (http://www.ncbi.nlm.nih.gov/pubmed/1851062)

Sarin S, Bernath A. “Turcot syndrome (glioma polyposis) : a case report.” The Southern Medical Journal. 2008 Dec;101(12):1273-4. (http://www.ncbi.nlm.nih.gov/pubmed/19005436)

Seaman V, Jumaan A, Yanni E, Lewis B, Neyer J, Roda P, Xu M, Hoffman R. “Use of molecular testing to identify a cluster of patients with polycythemia vera in eastern Pennsylvania.” Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2009 Feb;18(2):534-40. Epub 2009 Feb 3. (http://www.ncbi.nlm.nih.gov/pubmed/19190168)

Shareef MM, Brown B, Shajahan S, Sathishkumar S, Arnold SM, Mohiuddin M, Ahmed MM, Spring PM. “Lack of P-glycoprotein expression by low-dose fractionated radiation results from loss of nuclear factor-kappaB and NF-Y activation in oral carcinoma cells.” Mol Cancer Res. 2008 Jan;6(1):89-98. (http://www.ncbi.nlm.nih.gov/pubmed/18234965)

Shareef MM, Cui N, Burikhanov R, Gupta S, Satishkumar S, Shajahan S, Mohiuddin M, Rangnekar VM, Ahmed MM. “Role of tumor necrosis factor-alpha and TRAIL in high-dose radiation-induced bystander signaling in lung adenocarcinoma.” Cancer Res. 2007 Dec 15;67(24):11811-20. (http://www.ncbi.nlm.nih.gov/pubmed/18089811)

Siegelmann-Danieli N, Khandelwal V, Wood GC, Mainali R, Prichard J, Murphy TJ, Evans JF, Yumen O, Bernath AM. “Breast cancer in elderly women: outcome as affected by age, tumor features, comorbidities, and treatment approach.” Clinical Breast Cancer. 2006 Apr;7(1):59-66. (http://www.ncbi.nlm.nih.gov/pubmed/16764745)

Zagurovskaya M, Shareef MM, Das A, Reeves A, Gupta S, Sudol M, Bedford MT, Prichard J, Mohiuddin M, Ahmed MM. “EGR-1 forms a complex with YAP-1 and upregulates Bax expression in irradiated prostate carcinoma cells.” Oncogene. 2009 Feb 26;28(8):1121-31. (http://www.ncbi.nlm.nih.gov/pubmed/19137013)

Zhang PL, Quiery AT Jr, Blasick TM, Brown RE. “Morphoproteomic expression of H-ras (p21ras) correlates with serum monoclonal immunoglobulin reduction in multiple myeloma patients following pamidronate treatment.” Ann Clin Lab Sci. 2007 Winter;37(1):34-8. (http://www.ncbi.nlm.nih.gov/pubmed/17311867).